Some people use GLP-1 medications for a defined period as part of an active weight loss phase, while others remain on them longer-term for weight management, particularly if weight regain is a clinical concern
This article explains the trial-based dosing rationale, escalation schedules, influencing factors, side effects, and the current regulatory status in the UK
PMID: 25277394
Back Kreymann, B, Ghatei, MA, Williams, G, Bloom, SR (5 Dec 1987), The Lancet , 330/8571, 1300-04
Understanding proper storage requirements is essential for patients using these medications, as improper handling can compromise treatment outcomes and represent a significant financial loss given the cost of these therapies
Moreover, bone microarchitecture/strength changes assessed by high-resolution peripheral quantitative computed tomography (HR-pQCT) are lacking